These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 21542101

  • 1. Perioperative rupture of the LIMA graft leading to cardiogenic shock, emergency angiography, and stenting with a polytetrafluoroethylene-covered stent.
    Yeow WL, Edwards M, Yong G.
    Catheter Cardiovasc Interv; 2012 Mar 01; 79(4):640-3. PubMed ID: 21542101
    [Abstract] [Full Text] [Related]

  • 2. Successful deployment of polytetrafluoroethylene-covered stent to seal left internal mammary artery graft perforation due to guide catheter extension system.
    Ichimoto E, De Gregorio J.
    Cardiovasc Revasc Med; 2016 Dec 01; 17(8):574-577. PubMed ID: 27394179
    [Abstract] [Full Text] [Related]

  • 3. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE, Smits PC, Kereiakes DJ, Parise H, Fahy M, Kedhi E, Serruys PW, Lansky AJ, Cristea E, Sudhir K, Sood P, Simonton CA, Stone GW.
    JACC Cardiovasc Interv; 2011 Nov 01; 4(11):1209-15. PubMed ID: 22115661
    [Abstract] [Full Text] [Related]

  • 4. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M, Serruys PW, Miquel-Hebert K, Neumann FJ, Piek JJ, Grube E, Haase J, Thuesen L, Hamm C.
    Catheter Cardiovasc Interv; 2010 Jun 01; 75(7):997-1003. PubMed ID: 20517959
    [Abstract] [Full Text] [Related]

  • 5. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
    Barlis P, Horrigan M, Elis S, Chan R, Wong M, Farouque O, Proimos G, Ajani AE, Clark DJ.
    Cardiovasc Revasc Med; 2007 Jun 01; 8(2):84-9. PubMed ID: 17574165
    [Abstract] [Full Text] [Related]

  • 6. Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation.
    Ovünç K, Yorgun H, Ozer N.
    Cardiovasc Revasc Med; 2009 Jun 01; 10(4):252-4. PubMed ID: 19815173
    [Abstract] [Full Text] [Related]

  • 7. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
    Gioia G, Matthai W, Gillin K, Dralle J, Benassi A, Gioia MF, White J.
    Catheter Cardiovasc Interv; 2007 Jul 01; 70(1):26-33. PubMed ID: 17585381
    [Abstract] [Full Text] [Related]

  • 8. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M, Vassilev D, Fraccaro C, Roncon L, Faggian G.
    Cardiovasc Revasc Med; 2014 Mar 01; 15(2):76-9. PubMed ID: 24560299
    [Abstract] [Full Text] [Related]

  • 9. Unusual balloon rupture during direct stenting with a TaxusExpress stent in a venous graft complicated by vessel rupture: a device-related fatal event.
    Christiansen EH.
    J Interv Cardiol; 2007 Feb 01; 20(1):23-5. PubMed ID: 17300393
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study.
    Salvatella N, Morice MC, Darremont O, Tafflet M, Garot P, Leymarie JL, Chevalier B, Lefèvre T, Louvard Y, Boudou N, Dumonteil N, Carrié D.
    EuroIntervention; 2011 Oct 30; 7(6):689-96. PubMed ID: 21986327
    [Abstract] [Full Text] [Related]

  • 12. Rheolytic effects of left main mid-shaft/distal stenting: a computational flow dynamic analysis.
    Rigatelli G, Zuin M, Dell'Avvocata F, Nguyen T.
    Ther Adv Cardiovasc Dis; 2018 Jun 30; 12(6):161-168. PubMed ID: 29589515
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial.
    Blazek S, Rossbach C, Borger MA, Fuernau G, Desch S, Eitel I, Stiermaier T, Lurz P, Holzhey D, Schuler G, Mohr FW, Thiele H.
    JACC Cardiovasc Interv; 2015 Jan 30; 8(1 Pt A):30-8. PubMed ID: 25499302
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug-eluting versus bare metal coronary stents: long-term human pathology. Findings from different coronary arteries in the same patient.
    Guagliumi G, Virmani R, Musumeci G, Motta T, Valsecchi O, Bonaldi G, Saino A, Tespili M, Greco N, Farb A.
    Ital Heart J; 2003 Oct 30; 4(10):713-20. PubMed ID: 14664285
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Usefulness of rotational atherectomy in preventing polymer damage of everolimus-eluting stent in calcified coronary artery.
    Kuriyama N, Kobayashi Y, Yamaguchi M, Shibata Y.
    JACC Cardiovasc Interv; 2011 May 30; 4(5):588-9. PubMed ID: 21596335
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.